TG Therapeutics, Inc. (TGTX)

TG Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	129.13	179.89	92.93	102.3	298.89	553.44
Short-Term Investments	122.74	131.11	124.58	59.37	15.88	51.99
Cash & Short-Term Investments	251.87	311	217.51	161.68	314.76	605.43
Cash Growth	15.93%	42.98%	34.53%	-48.63%	-48.01%	331.11%
Accounts Receivable	231.52	129.19	51.09	-	1.39	-
Receivables	231.52	129.19	51.09	-	1.39	-
Inventory	155.2	110.46	39.82	-	-	-
Other Current Assets	25.37	15.72	9.52	6.6	14.81	6.31
Total Current Assets	663.96	566.36	317.94	168.27	330.97	611.74
Property, Plant & Equipment	6.72	7.15	8.05	9.2	9.23	9.79
Long-Term Investments	28.59	0.81	-	12.4	35.53	-
Goodwill	-	-	-	0.8	0.8	0.8
Long-Term Deferred Charges	-	-	-	1.63	1.84	2.05
Other Long-Term Assets	3.34	3.37	3.59	1.27	1.26	1.26
Total Assets	702.61	577.69	329.59	193.57	379.63	625.64
Accounts Payable	86.52	26.3	29.27	42.02	50.89	37.01
Accrued Expenses	10.61	15.19	12.17	8.43	10.17	8.46
Current Portion of Long-Term Debt	0.81	0.66	0.36	0.24	1.34	23.12
Current Portion of Leases	1.09	1.16	1.45	1.58	1.44	1.67
Current Unearned Revenue	23.91	11.41	0.15	-	0.2	0.2
Other Current Liabilities	48.95	35.97	10.32	0.93	1.35	17.1
Total Current Liabilities	171.89	90.68	53.72	53.2	65.38	87.55
Long-Term Debt	245.04	244.43	100.12	71.14	66.79	7.72
Long-Term Leases	7.59	8.13	9.23	10.34	9.85	10.41
Long-Term Unearned Revenue	1.67	12.09	6.02	0.31	0.46	0.61
Total Liabilities	426.18	355.33	169.09	134.99	142.48	106.29
Common Stock	0.16	0.16	0.15	0.15	0.14	0.14
Additional Paid-In Capital	1,794	1,760	1,713	1,586	1,566	1,500
Retained Earnings	-1,496	-1,529	-1,553	-1,527	-1,329	-980.6
Treasury Stock	-21.99	-8.99	-0.23	-0.23	-0.23	-0.23
Shareholders' Equity	276.43	222.36	160.5	58.59	237.15	519.35
Total Liabilities & Equity	702.61	577.69	329.59	193.57	379.63	625.64
Total Debt	254.53	254.38	111.15	83.3	79.41	42.91
Net Cash (Debt)	-2.66	56.62	106.36	78.38	235.36	562.51
Net Cash Growth	-	-46.76%	35.70%	-66.70%	-58.16%	465.67%
Net Cash Per Share	-0.02	0.35	0.72	0.58	1.78	4.88
Filing Date Shares Outstanding	145.9	145.23	144.78	137.63	130.79	129.8
Total Common Shares Outstanding	145.26	143.99	141.79	137.65	131.22	129.79
Working Capital	492.07	475.68	264.22	115.07	265.58	524.19
Book Value Per Share	1.90	1.54	1.13	0.43	1.81	4.00
Tangible Book Value	276.43	222.36	160.5	57.79	236.35	518.55
Tangible Book Value Per Share	1.90	1.54	1.13	0.42	1.80	4.00

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q